TABLE 2—
Weighted Frequencies of Hormone Use for Trans People in Ontario: Trans PULSE Project, 2009–2010
| Variable | Current Users (n = 233), % (95% CI) |
| Ever used nonprescribed hormones | 26.8 (18.0, 36.7) |
| Hormone regimena | |
| Progesterone | 13.2 (6.5, 26.7) |
| Estrogen | 54.9 (40.1, 68.9) |
| Antiandrogens | 30.7 (19.8, 42.2) |
| Testosterone | 42.7 (27.3, 57.0) |
| Sources of hormonesa | |
| Family doctor | 67.3 (51.9, 81.4) |
| Specialist | 30.9 (19.9, 46.1) |
| Internet pharmacy | 1.4 (0.1, 5.0) |
| Friend or relative | 4.7 (0.8, 9.7) |
| Street or strangers | …b |
| Herbals or supplements | 3.2 (0.0, 6.9) |
| Received blood tests to monitor hormones | |
| Regularly | 70.2 (66.8, 84.2) |
| Not regularly | 24.9 (12.3, 29.3) |
| No | 4.9 (0.7, 8.6) |
| Inject hormones | 50.3 (35.1, 61.6) |
| Source(s) of syringes or needlesac | |
| Pharmacy | 49.0 (25.6, 67.5) |
| Doctor’s office | 39.6 (21.5, 60.3) |
| Friends | 12.5 (2.6, 32.5) |
| Needle exchange | 19.4 (7.4, 37.3) |
Note. CI = confidence interval; trans = transgender or transsexual.
a
Check-all-that-apply item, so totals will not sum to 100%.
b
Group was too small to generate weighted prevalence estimates and confidence intervals.
c
Based on subgroup of participants who injected hormones.